Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through Commercialization, announced the addition of former regulators with significant expertise in oncology, immunotherapy and rare disease to its Regulatory & Access Consulting team, further supporting the advancement of new treatments for patients worldwide.
July 23, 2020
· 4 min read